As of January 22, 2025, Immunocore (IMCR) has a market cap of $1.51 billion USD. According to our data, Immunocore is ranked No.4575 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.51 B |
2.22%
|
Dec 31, 2024 | $1.48 B |
-56.82%
|
Dec 29, 2023 | $3.42 B |
19.71%
|
Dec 30, 2022 | $2.86 B |
66.68%
|
Dec 31, 2021 | $1.71 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Adaptimmune Therapeutics
ADAP
|
$0.14 B |
0.000 M
|
UK
|
bluebird bio
BLUE
|
$77.02 M |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
-0.000 M
|
USA
|
Iovance Biotherapeutics
IOVA
|
$1.78 B |
-0.017 B
|
USA
|
Legend Biotech
LEGN
|
$6.80 B |
-0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.19 B |
0.000 M
|
USA
|
Moderna
MRNA
|
$14.88 B |
0.000 M
|
USA
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.23 B |
-0.000 M
|
USA
|
Market Cap | = | IMCR Stock Price | * | IMCR Shares Outstanding |
= | $30.16 | * | 50.03 M | |
= | $1.51 B |